Aortic Valve Replacement Clinical Trial
Official title:
Preliminary Study of a Homoeopathic Association in Patients Undergoing Aortic Valve Surgery.
Randomized, parallel group, placebo controlled study to assess the effect of an homoeopathic
association of Arnica 5 CH et Bryonia 9 CH during aortic valve surgery with extra corporeal
circulation, to alleviate inflammation, haemorrhage, myocardial ischemia and pain. This is a
pilot study; a confirmative study will be set up if this study is positive.
The study treatment will start the day before surgery, and will comprise 5 granules of each
homoeopathic medication, Arnica 5 CH and Bryonia 9 CH, or their matching placebo TID during
5 days, in addition to all routine treatments.) Two groups of 45 patients will be included.
Patients have to be over 18 years, to undergo aortic valve surgery only, have no known
allergy to one of the study drugs, sign a consent form, and must not have received anti
inflammatory drug in the 3 days before surgery. The primary criteria include the amount of
drained liquid from the chest, and the CRP evolution from baseline to the 7th postoperative
day. Secondary criteria address inflammation, haemorrhage, ischaemia, and pain. A follow-up
phone call is given to the patients 30 days after their surgery.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05107453 -
Serratus Anterior Plane Block for Minimal Invasive Cardiac Surgery
|
Phase 4 | |
| Completed |
NCT01651780 -
Open-label, Randomized Trial in Patients Undergoing TAVR to Determine Safety & Efficacy of Bivalirudin vs UFH
|
Phase 3 | |
| Completed |
NCT01187329 -
The Effect of the Hyperinsulinemic Normoglycemic Clamp on Myocardial Function and Utilization of Glucose
|
N/A | |
| Recruiting |
NCT05295628 -
Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR
|
N/A | |
| Enrolling by invitation |
NCT03680040 -
RESILIENCE Trial: Evaluation of the Durability of Aortic Bioprostheses/Valves With RESILIA Tissue in Subjects Under 65
|
||
| Recruiting |
NCT05539937 -
Prospective Evaluation of the Quality of Life of Elderly Patients Undergoing Transfemoral Percutanous Aortic Valve Replacement (TAVI) for the Treatment of Severe Aortic Stenosis.
|
||
| Recruiting |
NCT01522352 -
Comparison Between Three Types of Stented Pericardial Aortic Valves
|
N/A | |
| Completed |
NCT01554709 -
Safety and Performance Study of the CardioGard Cannula
|
Phase 2/Phase 3 | |
| Suspended |
NCT04902053 -
INSPIRIS RESILIA Aortic Valve, Valve-in-Valve Surveillance Study
|
||
| Completed |
NCT01404975 -
TAVI Protocol - Paravertebral Block Study
|
N/A | |
| Recruiting |
NCT03889288 -
Innovative Device for Pain Management by Millimeter Band Radiation: Electronic-Pain Killer
|
N/A | |
| Active, not recruiting |
NCT05404880 -
INSPIRIS China PMCF Study
|
||
| Recruiting |
NCT04652375 -
Outcomes After Albumin vs Lactated Ringer's Solution in CABG and AVR Procedures
|
N/A | |
| Recruiting |
NCT06106451 -
Optimization Post-TAVR to IMprove Activity Levels (OPTIMAL Study)
|
N/A | |
| Completed |
NCT00860730 -
PERCEVAL Pivotal Trial
|
N/A | |
| Active, not recruiting |
NCT00396760 -
Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
|
Phase 3 | |
| Not yet recruiting |
NCT03603483 -
Aortic Root Enlargement in Aortic Valve Replacement
|
N/A | |
| Terminated |
NCT01368666 -
Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark
|
N/A | |
| Recruiting |
NCT03002272 -
Transcatheter Aortic Prosthesis Function: A Long-term Follow-up Study
|
||
| Active, not recruiting |
NCT03258333 -
Small Aortic Annulus - a New Solution to the Old Problem
|
N/A |